Stay updated on ATH-1017 in Mild to Moderate Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the ATH-1017 in Mild to Moderate Alzheimer's Clinical Trial page.

Latest updates to the ATH-1017 in Mild to Moderate Alzheimer's Clinical Trial page
- Check6 days agoChange DetectedThe record history now includes a new revision entry for v3.4.3 and removes v3.4.2 from the list.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedSponsor changed from Athira Pharma to LeonaBio in the study record. This affects the listed responsible party and contact information for the trial.SummaryDifference0.1%

- Check34 days agoChange DetectedA new Revision: v3.4.2 entry was added to the record history, and the prior Notice about government funding plus Revision: v3.4.1 were removed.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a site-wide funding-status notice and updated the record revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check49 days agoChange DetectedThe history view gains a glossary toggle and green/red highlights to distinguish additions and deletions; the revision metadata now displays v3.4.0 and No FEAR Act Data.SummaryDifference0.5%

- Check84 days agoChange DetectedRevision: v3.3.3 was added to the page history; references to HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to ATH-1017 in Mild to Moderate Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ATH-1017 in Mild to Moderate Alzheimer's Clinical Trial page.